Winnipeg, Manitoba

Cytophage Technologies Inc. is a corporation that develops bacteriophage products to prevent and treat bacterial infections affecting human health, animal health and food security. Our technology allows us to generate bacteriophage products to address bacterial infections and overcome the inherent limitations of naturally occurring phages. With a number of bacteriophages in its animal health products pipeline, Cytophage is currently evaluating opportunities to enter the human health market including compassionate use and therapeutic applications related to COVID-19.

Our vision for Cytophage is that every hospital, every veterinarian and every agricultural facility will have a supply of Cytophage products to manage any incumbent or emergent bacterial infection or contamination.